retatrutide peptide trials 🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in GLP-3 Retatrutide (12mg vials) -

Free radicals are unstable molecules that can damage cells, leading to inflammation, ageing and chronic disease

Zivkovic TB, Vuksanovic M, Jelic MA, Stojanovic J, Buric B, et al

[18:55] A I just, like, I don't

Write down questions you want to ask

Lets find that perfect rhythm that keeps you feeling sharp and energized

Recurrent associations between dysbiotic microbial patterns and poor metabolic response further support the hypothesis that gut microbiota may contribute to interindividual differences in response to incretin-based therapies, although definitive mechanistic evidence in humans remains limited (136), and causality between specific microbial taxa, functional pathways, and GLP-1 RA responsiveness cannot be inferred